» Articles » PMID: 37220236

Effects of Lifestyle Modification on Psychosocial Function in Patients With Resistant Hypertension: SECONDARY OUTCOMES FROM THE TRIUMPH RANDOMIZED CLINICAL TRIAL

Abstract

Purpose: In a secondary analysis of the TRIUMPH clinical trial, psychological outcomes in patients with resistant hypertension (RH) receiving a diet and exercise intervention delivered in a cardiac rehabilitation setting were compared with those receiving a similar prescription of diet and exercise provided in a single counseling session by a health educator.

Methods: One hundred forty patients with RH were randomly assigned to a 4-mo program of dietary counseling, behavioral weight management, and exercise (C-LIFE) or a single counseling session providing standardized education and physician advice (SEPA). Participants completed a battery of questionnaires to assess psychological functioning before and after the intervention. A global measure of psychological functioning was derived from the General Health Questionnaire (GHQ), Perceived Stress Scale (PSS), Medical Outcomes Study 36-item Short Form Health Survey, Spielberger State-Trait Anxiety Inventory, Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory-II, and Patient-Reported Outcomes Measurement Information System (PROMIS) Anger scale.

Results: Participants in the C-LIFE intervention achieved greater improvements in psychological functioning compared with SEPA (C-LIFE: 58.9 [56.1, 61.8] vs SEPA: 66.5 [62.1, 70.9]; P = .024). Greater improvements were especially evident for the GHQ, PSS, and HADS. Examination of mediation revealed that greater weight loss ( B =-0.17, P = .004) and improved oxygen uptake ( B =-0.12, P = .044) were associated with improved psychological functioning.

Conclusion: Compared with standard education and physician advice, a structured program of diet and exercise not only reduced blood pressure but also improved psychological functioning in patients with RH.

Citing Articles

Diabetes Mellitus and Hyperlipidemia Status Among Hypertensive Patients in the Community and Influencing Factors Analysis of Blood Pressure Control.

Zhang S, Yang Y, Chen X, Fan L, Wu J, Liu X J Clin Hypertens (Greenwich). 2025; 27(2):e14965.

PMID: 39999366 PMC: 11856054. DOI: 10.1111/jch.14965.


Counseling Intervention and Cardiovascular Events in People With Peripheral Artery Disease: A Post Hoc Analysis of the BIP Randomized Clinical Trial.

Golledge J, Venn A, Yip L, Leicht A, Jenkins J, Fiatarone Singh M JAMA Surg. 2024; 159(11):1262-1270.

PMID: 39167413 PMC: 11339702. DOI: 10.1001/jamasurg.2024.3083.


The Global Burden of Resistant Hypertension and Potential Treatment Options.

Buso G, Agabiti-Rosei C, Lemoli M, Corvini F, Muiesan M Eur Cardiol. 2024; 19:e07.

PMID: 38983582 PMC: 11231817. DOI: 10.15420/ecr.2023.51.


The Effect of Stress-Reducing Interventions on Heart Rate Variability in Cardiovascular Disease: A Systematic Review and Meta-Analysis.

El-Malahi O, Mohajeri D, Bauerle A, Mincu R, Rothenaicher K, Ullrich G Life (Basel). 2024; 14(6).

PMID: 38929732 PMC: 11204824. DOI: 10.3390/life14060749.


Engineering Virtuous health habits using Emotion and Neurocognition: Flexibility for Lifestyle Optimization and Weight management (EVEN FLOW).

Smith P, Whitson H, Merwin R, OHayer C, Strauman T Front Aging Neurosci. 2023; 15:1256430.

PMID: 38076541 PMC: 10702760. DOI: 10.3389/fnagi.2023.1256430.

References
1.
Azizi M, Saxena M, Wang Y, Jenkins J, Devireddy C, Rader F . Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. JAMA. 2023; 329(8):651-661. PMC: 9975904. DOI: 10.1001/jama.2023.0713. View

2.
Lopes S, Mesquita-Bastos J, Garcia C, Bertoquini S, Ribau V, Teixeira M . Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension: A Randomized Clinical Trial. JAMA Cardiol. 2021; 6(11):1317-1323. PMC: 8340008. DOI: 10.1001/jamacardio.2021.2735. View

3.
Harsha D, Lin P, Obarzanek E, Karanja N, Moore T, Caballero B . Dietary Approaches to Stop Hypertension: a summary of study results. DASH Collaborative Research Group. J Am Diet Assoc. 1999; 99(8 Suppl):S35-9. DOI: 10.1016/s0002-8223(99)00414-9. View

4.
Williams B, MacDonald T, Morant S, Webb D, Sever P, McInnes G . Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018; 6(6):464-475. PMC: 5966620. DOI: 10.1016/S2213-8587(18)30071-8. View

5.
Carey R, Calhoun D, Bakris G, Brook R, Daugherty S, Dennison-Himmelfarb C . Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018; 72(5):e53-e90. PMC: 6530990. DOI: 10.1161/HYP.0000000000000084. View